Tenax Therapeutics (TENX) Receivables - Accured (2014 - 2021)
Tenax Therapeutics (TENX) reported Receivables - Accured of $4690.0 for Q2 2021, up 35.9% on a YoY basis from $3451.0 in Q2 2020, and up 39.71% sequentially from $3357.0 in Q1 2021.
Tenax Therapeutics (TENX) Receivables - Accured (2014 - 2021) Analysis & Trends
Tenax Therapeutics (TENX) has 8 years of Receivables - Accured data on file, last reported at $4690.0 in Q2 2021.
- For the quarter ending Q2 2021, Receivables - Accured rose 35.9% year-over-year to $4690.0; the trailing twelve-month figure through Jun 2021 stood at $4690.0 (up 35.9% YoY), and the FY2020 full-year result was $3551.0, up 32.15% from the prior year.
- Receivables - Accured rose to $4690.0 in Q2 2021, from $3357.0 in the prior quarter.
- In the past five years, Receivables - Accured ranged from a high of $89425.0 in Q1 2017 to a low of $2197.0 in Q4 2018.
- A 5-year average of $22879.6 and a median of $3573.5 in 2020 frame the typical range for Receivables - Accured.
- Across the five-year window, Receivables - Accured tumbled 96.82% in 2018 and soared 38.76% in 2020, its largest moves.
- Tracing TENX's Receivables - Accured over 5 years: stood at $69066.0 in 2017, then plunged by 96.82% to $2197.0 in 2018, then grew by 22.3% to $2687.0 in 2019, then surged by 32.15% to $3551.0 in 2020, then jumped by 32.08% to $4690.0 in 2021.
- Business Quant data shows TENX's Receivables - Accured at $4690.0 in Q2 2021, $3357.0 in Q1 2021, and $3551.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 4,690.00 |
| Jun 30, 2021 | 4,690.00 |
| Mar 31, 2021 | 3,357.00 |
| Mar 31, 2021 | 3,357.00 |
| Dec 31, 2020 | 3,551.00 |
| Dec 31, 2020 | 3,551.00 |
| Sep 30, 2020 | 3,239.00 |
| Sep 30, 2020 | 3,239.00 |
| Jun 30, 2020 | 3,451.00 |
| Jun 30, 2020 | 3,451.00 |
| Mar 31, 2020 | 3,596.00 |
| Mar 31, 2020 | 3,596.00 |
| Dec 31, 2019 | 2,687.00 |
| Dec 31, 2019 | 2,687.00 |
| Sep 30, 2019 | 3,013.00 |
| Sep 30, 2019 | 3,013.00 |
| Jun 30, 2019 | 2,487.00 |
| Jun 30, 2019 | 2,487.00 |
| Mar 31, 2019 | 2,865.00 |
| Mar 31, 2019 | 2,865.00 |